Royalty Pharma’s Acquisition of Royalty Interest in SPINRAZA and Pelacarsen from Ionis

Fenwick and Goodwin represented Royalty Pharma on the deal.Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry, announced Royalty…